Document Leak: NICE Says No to MS


Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-09-01-2001
Volume 0
Issue 0

London-Schering and Biogen have both expressed anger over the leak of a National Institute of Clinical Excellence (NICE) document suggesting that doctors stop prescribing beta-interferon to new multiple sclerosis (MS) patients.

Related Videos
Jason Tate, FSP Talent Strategy Lead, PPD, part of Thermo Fisher Scientific
Related Content